117 related articles for article (PubMed ID: 38705555)
1. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
[TBL] [Abstract][Full Text] [Related]
2. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
Mirza R; Sharma B
Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
[TBL] [Abstract][Full Text] [Related]
3. The protective role of prenatal administration of ascorbic acid on autistic-like behavior in a rat model of autism.
Margedari P; Goudarzi I; Sepehri H
IBRO Neurosci Rep; 2024 Jun; 16():78-85. PubMed ID: 38274439
[TBL] [Abstract][Full Text] [Related]
4. The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally.
Shafaghi A; Vakili Shahrbabaki SS; Aminzadeh A; Heidari MR; Shamsi Meymandi M; Bashiri H
Neurotoxicol Teratol; 2022; 89():107050. PubMed ID: 34801733
[TBL] [Abstract][Full Text] [Related]
5. Validation of prenatal versus postnatal valproic acid rat models of autism: A behavioral and neurobiological study.
Elnahas EM; Abuelezz SA; Mohamad MI; Nabil MM; Abdelraouf SM; Bahaa N; Hassan GA; Ibrahim EA; Ahmed AI; Aboul-Fotouh S
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110185. PubMed ID: 33238165
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A supplementation ameliorates prenatal valproic acid-induced autism-like behaviors in rats.
Liu Z; Wang J; Xu Q; Wu Z; You L; Hong Q; Zhu J; Chi X
Neurotoxicology; 2022 Jul; 91():155-165. PubMed ID: 35594946
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of the standardised extract of Bacopa monnieri (BacoMind) in valproic acid model of autism spectrum disorder in rats.
Abhishek M; Rubal S; Rohit K; Rupa J; Phulen S; Gurjeet K; Raj SA; Manisha P; Alka B; Ramprasad P; Bikash M
J Ethnopharmacol; 2022 Jul; 293():115199. PubMed ID: 35346813
[TBL] [Abstract][Full Text] [Related]
8. Novel potential of metformin on valproic acid-induced autism spectrum disorder in rats: involvement of antioxidant defence system.
Ishola IO; Balogun AO; Adeyemi OO
Fundam Clin Pharmacol; 2020 Dec; 34(6):650-661. PubMed ID: 32415700
[TBL] [Abstract][Full Text] [Related]
9. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the ERK1/2 Phosphorylation by Dextromethorphan Protects against Core Autistic Symptoms in VPA Induced Autistic Rats:
Singla R; Mishra A; Joshi R; Kumar R; Sarma P; Sharma AR; Kaur G; Bhatia A; Medhi B
ACS Chem Neurosci; 2021 May; 12(10):1749-1767. PubMed ID: 33913688
[TBL] [Abstract][Full Text] [Related]
11. Prangos ferulacea (L.) ameliorates behavioral alterations, hippocampal oxidative stress markers, and apoptotic deficits in a rat model of autism induced by valproic acid.
Saadat M; Taherian AA; Aldaghi MR; Raise-Abdullahi P; Sameni HR; Vafaei AA
Brain Behav; 2023 Nov; 13(11):e3224. PubMed ID: 37596045
[TBL] [Abstract][Full Text] [Related]
12. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats.
Viana CE; Bortolotto VC; Araujo SM; Dahleh MMM; Machado FR; de Souza Pereira A; Moreira de Oliveira BP; Leimann FV; Gonçalves OH; Prigol M; Guerra GP
Neurotoxicology; 2023 Jan; 94():223-234. PubMed ID: 36528186
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of cognition impairments in the valproic acid-induced animal model of autism by ciproxifan, a histamine H3-receptor antagonist.
Taheri F; Esmaeilpour K; Sepehri G; Sheibani V; Shekari MA
Behav Pharmacol; 2023 Jun; 34(4):179-196. PubMed ID: 37171458
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte Colony-Stimulating Factor Improved Core Symptoms of Autism Spectrum Disorder via Modulating Glutamatergic Receptors in the Prefrontal Cortex and Hippocampus of Rat Brains.
Mishra A; Singla R; Kumar R; Sharma A; Joshi R; Sarma P; Kaur G; Prajapat M; Bhatia A; Medhi B
ACS Chem Neurosci; 2022 Oct; 13(20):2942-2961. PubMed ID: 36166499
[TBL] [Abstract][Full Text] [Related]
15. GABA
Wang X; Zhao Z; Guo J; Mei D; Duan Y; Zhang Y; Gou L
Brain Res Bull; 2023 Oct; 202():110755. PubMed ID: 37678443
[TBL] [Abstract][Full Text] [Related]
16. Improvement of autistic-like behaviors in adult rats prenatally exposed to valproic acid through early suppression of NMDA receptor function.
Mohammadi S; Asadi-Shekaari M; Basiri M; Parvan M; Shabani M; Nozari M
Psychopharmacology (Berl); 2020 Jan; 237(1):199-208. PubMed ID: 31595334
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
Mirza R; Sharma B
Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
[TBL] [Abstract][Full Text] [Related]
18. Chronic inhibition of astrocytic aquaporin-4 induces autistic-like behavior in control rat offspring similar to maternal exposure to valproic acid.
Davoudi S; Rahdar M; Hosseinmardi N; Behzadi G; Janahmadi M
Physiol Behav; 2023 Oct; 269():114286. PubMed ID: 37402416
[TBL] [Abstract][Full Text] [Related]
19. Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism.
Al-Amin MM; Rahman MM; Khan FR; Zaman F; Mahmud Reza H
Behav Brain Res; 2015 Jun; 286():112-21. PubMed ID: 25732953
[TBL] [Abstract][Full Text] [Related]
20. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
